ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2023
A Study on Myloblastosis Gene (MYB) in Adenoid Cystic Carcinoma Using the New IHC Marker MYB (SZ04-81).
Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
- A case report of adenoid cystic carcinoma combined with giant renal metastasis treated with robotic surgery.Discover oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aim: Adenoid cystic carcinoma is one of the most common malignant neoplasms of the salivary gland. It has overlapping histological features with other salivary gland tumors. MYB is a nuclear marker which is known to be expressed in Adenoid cystic carcinoma. In this study we aim to determine the sensitivity and specificity of MYB IHC marker to differentiate Adenoid cystic carcinoma from other benign and malignant salivary gland tumors. Materials and method: This is a retrospective case control study on the paraffin blocks of 78 cases of salivary gland tumors obtained over a period of 5 years. MYB Ser11 monoclonal antibody of clone SZ04-81 IHC, a nuclear marker was done on all cases. The results observed was tabulated and statistical analysis was done to calculate the sensitivity and specificity of the MYB IHC marker. Results: The mean age group of Adenoid cystic carcinoma was 45 years with a female preponderance. 60% of the cases of Adenoid cystic carcinoma were from minor salivary glands spread across various sites. The sensitivity and specificity of the MYB IHC marker were statistically analyzed and found to be 93.9% and 97.8% respectively. Conclusion: The present study shows substantial expression of MYB immunohistochemical marker in Adenoid cystic carcinoma, with a very high sensitivity and specificity obtained using the clone SZ04-81. Thus this marker can be used in the diagnosis of adenoid cystic carcinoma. However, correlation with H & E and FISH studies are required. Supplementary Information: The online version contains supplementary material available at 10.1007/s12070-023-03471-4.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.